These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

341 related items for PubMed ID: 19997094

  • 1. Increased proteasome-mediated degradation of occludin in irritable bowel syndrome.
    Coëffier M, Gloro R, Boukhettala N, Aziz M, Lecleire S, Vandaele N, Antonietti M, Savoye G, Bôle-Feysot C, Déchelotte P, Reimund JM, Ducrotté P.
    Am J Gastroenterol; 2010 May; 105(5):1181-8. PubMed ID: 19997094
    [Abstract] [Full Text] [Related]

  • 2. Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome: involvement of soluble mediators.
    Piche T, Barbara G, Aubert P, Bruley des Varannes S, Dainese R, Nano JL, Cremon C, Stanghellini V, De Giorgio R, Galmiche JP, Neunlist M.
    Gut; 2009 Feb; 58(2):196-201. PubMed ID: 18824556
    [Abstract] [Full Text] [Related]

  • 3. The expression and the cellular distribution of the tight junction proteins are altered in irritable bowel syndrome patients with differences according to the disease subtype.
    Bertiaux-Vandaële N, Youmba SB, Belmonte L, Lecleire S, Antonietti M, Gourcerol G, Leroi AM, Déchelotte P, Ménard JF, Ducrotté P, Coëffier M.
    Am J Gastroenterol; 2011 Dec; 106(12):2165-73. PubMed ID: 22008894
    [Abstract] [Full Text] [Related]

  • 4. T-cell activation in patients with irritable bowel syndrome.
    Ohman L, Isaksson S, Lindmark AC, Posserud I, Stotzer PO, Strid H, Sjövall H, Simrén M.
    Am J Gastroenterol; 2009 May; 104(5):1205-12. PubMed ID: 19367268
    [Abstract] [Full Text] [Related]

  • 5. [Changes of tight junction claudin-1,-3,-4 protein expression in the intestinal mucosa in patients with irritable bowel syndrome].
    Kong WM, Gong J, Dong L, Xu JR.
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Sep; 27(9):1345-7. PubMed ID: 17884774
    [Abstract] [Full Text] [Related]

  • 6. Functional bowel symptoms in quiescent inflammatory bowel diseases: role of epithelial barrier disruption and low-grade inflammation.
    Vivinus-Nébot M, Frin-Mathy G, Bzioueche H, Dainese R, Bernard G, Anty R, Filippi J, Saint-Paul MC, Tulic MK, Verhasselt V, Hébuterne X, Piche T.
    Gut; 2014 May; 63(5):744-52. PubMed ID: 23878165
    [Abstract] [Full Text] [Related]

  • 7. [Signal transduction pathway of colonic Toll-like receptor 4 in patients with irritable bowel syndrome].
    Wang XM, Liu YL.
    Zhonghua Yi Xue Za Zhi; 2008 Dec 30; 88(48):3415-7. PubMed ID: 19159572
    [Abstract] [Full Text] [Related]

  • 8. Luminal cysteine-proteases degrade colonic tight junction structure and are responsible for abdominal pain in constipation-predominant IBS.
    Annaházi A, Ferrier L, Bézirard V, Lévêque M, Eutamène H, Ait-Belgnaoui A, Coëffier M, Ducrotté P, Róka R, Inczefi O, Gecse K, Rosztóczy A, Molnár T, Ringel-Kulka T, Ringel Y, Piche T, Theodorou V, Wittmann T, Bueno L.
    Am J Gastroenterol; 2013 Aug 30; 108(8):1322-31. PubMed ID: 23711626
    [Abstract] [Full Text] [Related]

  • 9. Mucosal cytokine imbalance in irritable bowel syndrome.
    Macsharry J, O'Mahony L, Fanning A, Bairead E, Sherlock G, Tiesman J, Fulmer A, Kiely B, Dinan TG, Shanahan F, Quigley EM.
    Scand J Gastroenterol; 2008 Aug 30; 43(12):1467-76. PubMed ID: 18752146
    [Abstract] [Full Text] [Related]

  • 10. Diarrhoea-predominant irritable bowel syndrome: an organic disorder with structural abnormalities in the jejunal epithelial barrier.
    Martínez C, Lobo B, Pigrau M, Ramos L, González-Castro AM, Alonso C, Guilarte M, Guilá M, de Torres I, Azpiroz F, Santos J, Vicario M.
    Gut; 2013 Aug 30; 62(8):1160-8. PubMed ID: 22637702
    [Abstract] [Full Text] [Related]

  • 11. Activation of human enteric neurons by supernatants of colonic biopsy specimens from patients with irritable bowel syndrome.
    Buhner S, Li Q, Vignali S, Barbara G, De Giorgio R, Stanghellini V, Cremon C, Zeller F, Langer R, Daniel H, Michel K, Schemann M.
    Gastroenterology; 2009 Oct 30; 137(4):1425-34. PubMed ID: 19596012
    [Abstract] [Full Text] [Related]

  • 12. Intestinal serotonin release, sensory neuron activation, and abdominal pain in irritable bowel syndrome.
    Cremon C, Carini G, Wang B, Vasina V, Cogliandro RF, De Giorgio R, Stanghellini V, Grundy D, Tonini M, De Ponti F, Corinaldesi R, Barbara G.
    Am J Gastroenterol; 2011 Jul 30; 106(7):1290-8. PubMed ID: 21427712
    [Abstract] [Full Text] [Related]

  • 13. Mast cells and cellularity of the colonic mucosa correlated with fatigue and depression in irritable bowel syndrome.
    Piche T, Saint-Paul MC, Dainese R, Marine-Barjoan E, Iannelli A, Montoya ML, Peyron JF, Czerucka D, Cherikh F, Filippi J, Tran A, Hébuterne X.
    Gut; 2008 Apr 30; 57(4):468-73. PubMed ID: 18194987
    [Abstract] [Full Text] [Related]

  • 14. Multigene analysis can discriminate between ulcerative colitis, Crohn's disease, and irritable bowel syndrome.
    von Stein P, Lofberg R, Kuznetsov NV, Gielen AW, Persson JO, Sundberg R, Hellstrom K, Eriksson A, Befrits R, Ost A, von Stein OD.
    Gastroenterology; 2008 Jun 30; 134(7):1869-81; quiz 2153-4. PubMed ID: 18466904
    [Abstract] [Full Text] [Related]

  • 15. Mucosal immune activation in irritable bowel syndrome: gender-dependence and association with digestive symptoms.
    Cremon C, Gargano L, Morselli-Labate AM, Santini D, Cogliandro RF, De Giorgio R, Stanghellini V, Corinaldesi R, Barbara G.
    Am J Gastroenterol; 2009 Feb 30; 104(2):392-400. PubMed ID: 19174797
    [Abstract] [Full Text] [Related]

  • 16. Interleukin-8 and SDF1-alpha mRNA expression in colonic biopsies from patients with inflammatory bowel disease.
    Katsuta T, Lim C, Shimoda K, Shibuta K, Mitra P, Banner BF, Mori M, Barnard GF.
    Am J Gastroenterol; 2000 Nov 30; 95(11):3157-64. PubMed ID: 11095335
    [Abstract] [Full Text] [Related]

  • 17. CD4+CD25+ regulatory T cells in irritable bowel syndrome patients.
    Holmén N, Isaksson S, Simrén M, Sjövall H, Ohman L.
    Neurogastroenterol Motil; 2007 Feb 30; 19(2):119-25. PubMed ID: 17244166
    [Abstract] [Full Text] [Related]

  • 18. Elevated human beta-defensin-2 levels indicate an activation of the innate immune system in patients with irritable bowel syndrome.
    Langhorst J, Junge A, Rueffer A, Wehkamp J, Foell D, Michalsen A, Musial F, Dobos GJ.
    Am J Gastroenterol; 2009 Feb 30; 104(2):404-10. PubMed ID: 19174795
    [Abstract] [Full Text] [Related]

  • 19. [Expression of human beta-defensin 2 and tumor necrosis factor-A in colonic mucosae of ulcerative colitis and diarrhea-predominant irritable bowel syndrome].
    Li MR, Jiang K, Zhang QY.
    Zhonghua Yi Xue Za Zhi; 2008 Apr 08; 88(14):957-60. PubMed ID: 18756966
    [Abstract] [Full Text] [Related]

  • 20. Abnormal intestinal permeability in subgroups of diarrhea-predominant irritable bowel syndromes.
    Dunlop SP, Hebden J, Campbell E, Naesdal J, Olbe L, Perkins AC, Spiller RC.
    Am J Gastroenterol; 2006 Jun 08; 101(6):1288-94. PubMed ID: 16771951
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.